Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Front Immunol. 2020 Sep 24;11:572178. doi: 10.3389/fimmu.2020.572178. eCollection 2020.
IL-10 is an anti-inflammatory cytokine that plays a significant role in the modulation of the immune response in many pathological conditions, including infectious diseases. Infection with (), the etiological agent of Chagas disease, results in an ongoing inflammatory response that may cause heart dysfunction, ultimately leading to heart failure. Given its infectious and inflammatory nature, in this work we analyzed whether the lack of IL-10 hinders the anti-inflammatory effects of fenofibrate, a PPARα ligand, in a murine model of Chagas heart disease (CHD) using IL-10 knockout (IL-10 KO) mice. Our results show fenofibrate was able to restore the abnormal cardiac function displayed by infected mice lacking IL-10. Treatment with fenofibrate reduced creatine kinase (CK) levels in sera of IL-10 KO mice infected with Moreover, although fenofibrate could not modulate the inflammatory infiltrates developing in the heart, it was able to reduce the increased collagen deposition in infected IL-10 KO mice. Regarding pro-inflammatory mediators, the most significant finding was the increase in serum IL-17. These were reduced in IL-10 KO mice upon fenofibrate treatment. In agreement with this, the expression of RORγt was reduced. Infection of IL-10 KO mice increased the expression of YmI, FIZZ and Mannose Receptor (tissue healing markers) that remained unchanged upon treatment with fenofibrate. In conclusion, our work emphasizes the role of anti-inflammatory mechanisms to ameliorate heart function in CHD and shows, for the first time, that fenofibrate attains this through IL-10-dependent and -independent mechanisms.
白细胞介素-10(IL-10)是一种抗炎细胞因子,在许多病理条件下,包括传染病中,对免疫反应的调节起着重要作用。感染克氏锥虫(),恰加斯病的病原体,会导致持续的炎症反应,可能导致心脏功能障碍,最终导致心力衰竭。鉴于其感染和炎症性质,在这项工作中,我们分析了缺乏白细胞介素-10 是否会阻碍非诺贝特(PPARα 配体)在恰加斯病心脏病(CHD)的小鼠模型中的抗炎作用,方法是使用白细胞介素-10 敲除(IL-10 KO)小鼠。我们的结果表明,非诺贝特能够恢复缺乏白细胞介素-10 的感染小鼠异常的心脏功能。非诺贝特治疗降低了感染 的 IL-10 KO 小鼠血清中的肌酸激酶(CK)水平。此外,尽管非诺贝特不能调节心脏中发展的炎症浸润,但它能够减少感染的 IL-10 KO 小鼠中胶原沉积的增加。关于促炎介质,最显著的发现是血清白细胞介素-17 的增加。在非诺贝特治疗后,IL-10 KO 小鼠中的这些物质减少。这与 RORγt 的表达减少一致。IL-10 KO 小鼠的感染增加了 YmI、FIZZ 和甘露糖受体(组织修复标志物)的表达,而在用非诺贝特治疗后这些标志物的表达没有变化。总之,我们的工作强调了抗炎机制在改善 CHD 心脏功能中的作用,并首次表明,非诺贝特通过白细胞介素-10 依赖和非依赖机制实现这一目标。